BFM
ICCM icon

Boothbay Fund Management’s IceCure Medical ICCM Stock Holding History

Boothbay Fund Management’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,333
Closed -$46.4K – 1884
2023
Q2 		$46.4K Hold
1,333
– – ﹤0.01% 1676
2023
Q1 		$46K Hold
1,333
– – ﹤0.01% 2028
2022
Q4 		$62K Buy
1,333
+666
+100% +$23.9K ﹤0.01% 1865
2022
Q3 		$26K Hold
667
– – ﹤0.01% 2151
2022
Q2 		$34K Hold
667
– – ﹤0.01% 2133
2022
Q1 		$48K Hold
667
– – ﹤0.01% 2187
2021
Q4 		$61K Buy
+667
New +$111K ﹤0.01% 1762

Other funds holding ICCM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boothbay Fund Management's ICCM Position: Q3 2023 in Review

Boothbay Fund Management sold out of IceCure Medical (ICCM) in Q3 2023, closing a stake of 1,333 shares — an estimated $46.4K sold.

Boothbay Fund Management first reported a position in ICCM in Q4 2021 and held it in 7 quarters. The position peaked at $62K in Q4 2022. 12 funds tracked by Wall St. Rank hold ICCM as of Q3 2023.

  • Boothbay Fund Management reported no remaining IceCure Medical position as of Q3 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 1,333 IceCure Medical shares in Q3 2023, an estimated $46.4K.
  • Boothbay Fund Management first reported a position in IceCure Medical in Q4 2021 and held it in 7 quarters.
  • Boothbay Fund Management's IceCure Medical position peaked at $62K in Q4 2022.
  • 12 funds tracked by Wall St. Rank held IceCure Medical as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.